FDA Chief Reveals New Openness To Quicker Drug Approvals
The U.S. Food and Drug Administration's chief on Thursday outlined new openness to clearing drugs based on tentative signs of health benefits, a move that could help patients with few treatment...To view the full article, register now.
Already a subscriber? Click here to view full article